Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G T Mootrey

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2001
Safety data on meningococcal polysaccharide vaccine from the Vaccine Adverse Event Reporting SystemR Ball, M M Braun, G T Mootrey, et al.
The Journal of Allergy and Clinical Immunology|April 13, 1999
Anaphylaxis from yellow fever vaccineJ M Kelso, G T Mootrey, T F Tsai
Clinical Pharmacology and Therapeutics|November 1, 2007
Financing immunization of adults in the United StatesW A Orenstein, G T Mootrey, K Pazol, et al.
Pediatrics|May 23, 2001
Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccineW A Wattigney, G T Mootrey, M M Braun, et al.
Pediatrics|June 5, 2001
Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting systemL R Zanardi, P Haber, G T Mootrey, et al.
Pediatrics|October 4, 2000
Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS)M M Braun, G T Mootrey, M E Salive, et al.
Vaccine|August 7, 1999
An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working GroupJ A Singleton, J C Lloyd, G T Mootrey, et al.
Pharmacoepidemiology and Drug Safety|January 5, 2002
The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997L E Silvers, S S Ellenberg, R P Wise, et al.
JAMA|September 9, 2000
Postlicensure safety surveillance for varicella vaccineR P Wise, M E Salive, M M Braun, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2001
Safety data on meningococcal polysaccharide vaccine from the Vaccine Adverse Event Reporting SystemR Ball, M M Braun, G T Mootrey, et al.
The Journal of Allergy and Clinical Immunology|April 13, 1999
Anaphylaxis from yellow fever vaccineJ M Kelso, G T Mootrey, T F Tsai
Clinical Pharmacology and Therapeutics|November 1, 2007
Financing immunization of adults in the United StatesW A Orenstein, G T Mootrey, K Pazol, et al.
Pediatrics|May 23, 2001
Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccineW A Wattigney, G T Mootrey, M M Braun, et al.
Pediatrics|June 5, 2001
Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting systemL R Zanardi, P Haber, G T Mootrey, et al.
Pediatrics|October 4, 2000
Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS)M M Braun, G T Mootrey, M E Salive, et al.
Vaccine|August 7, 1999
An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working GroupJ A Singleton, J C Lloyd, G T Mootrey, et al.
Pharmacoepidemiology and Drug Safety|January 5, 2002
The epidemiology of fatalities reported to the vaccine adverse event reporting system 1990-1997L E Silvers, S S Ellenberg, R P Wise, et al.
JAMA|September 9, 2000
Postlicensure safety surveillance for varicella vaccineR P Wise, M E Salive, M M Braun, et al.
Pageof 1